{"entity":{"type":"insider","cik":"0001751790","url":"/insider/0001751790","json_url":"/insider/0001751790.json","name":"Wolff Stefani","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":10,"first":"2019-12-18","last":"2023-05-02","span_basis":"filed_date"},"name_variants":[{"name":"Wolff Stefani","source":"filing","n_filings":10,"first_seen":"2019-12-18","last_seen":"2023-05-02"}],"transactions":[{"id":7997986,"accession":"0001209191-23-026527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-026527","line_url":"/filing/0001209191-23-026527#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (EVP and COO)","role_mark":"O","role_mark_label":"Officer (EVP and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":342.0,"shares_display":"342","price_per_share":9.8763,"price_display":"9.88","price_state":"stated","total_value":3377.6946,"total_display":"3,377.69","total_whole":"3,378","shares_owned_after":6113.0,"shares_owned_after_display":"6,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8104769,"accession":"0001209191-23-005910","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-005910","line_url":"/filing/0001209191-23-005910#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (EVP and COO)","role_mark":"O","role_mark_label":"Officer (EVP and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424.0,"shares_display":"424","price_per_share":11.7796,"price_display":"11.78","price_state":"stated","total_value":4994.5504,"total_display":"4,994.55","total_whole":"4,995","shares_owned_after":3940.0,"shares_owned_after_display":"3,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":6658355,"accession":"0001209191-22-055136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055136","line_url":"/filing/0001209191-22-055136#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (EVP and COO)","role_mark":"O","role_mark_label":"Officer (EVP and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":12.8805,"price_display":"12.88","price_state":"stated","total_value":4508.175,"total_display":"4,508.18","total_whole":"4,508","shares_owned_after":3402.0,"shares_owned_after_display":"3,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-01","scope":"insider"},{"id":6106072,"accession":"0001209191-22-043963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043963","line_url":"/filing/0001209191-22-043963#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (EVP and COO)","role_mark":"O","role_mark_label":"Officer (EVP and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":356.0,"shares_display":"356","price_per_share":15.67,"price_display":"15.67","price_state":"stated","total_value":5578.52,"total_display":"5,578.52","total_whole":"5,579","shares_owned_after":1238.0,"shares_owned_after_display":"1,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6455330,"accession":"0001209191-22-026891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-026891","line_url":"/filing/0001209191-22-026891#line-2","is_derivative":false,"issuer_cik":"0001549595","issuer_name":"Nurix Therapeutics, Inc.","issuer_ticker":"NRIX","issuer_name_source":null,"issuer_url":"/issuer/0001549595","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (EVP and COO)","role_mark":"O","role_mark_label":"Officer (EVP and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":330.0,"shares_display":"330","price_per_share":11.75,"price_display":"11.75","price_state":"stated","total_value":3877.5,"total_display":"3,877.50","total_whole":"3,878","shares_owned_after":632.0,"shares_owned_after_display":"632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":2683283,"accession":"0001209191-20-037486","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-037486","line_url":"/filing/0001209191-20-037486","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5504.0,"shares_display":"5,504","price_per_share":60.75300472383721,"price_display":"60.75","price_state":"stated","total_value":334384.538,"total_display":"334,384.54","total_whole":"334,385","shares_owned_after":19196.0,"shares_owned_after_display":"19,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":3},{"id":9271201,"accession":"0001209191-20-037484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037484","line_url":"/filing/0001209191-20-037484","is_derivative":false,"issuer_cik":"0001751790","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001751790","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5504.0,"shares_display":"5,504","price_per_share":46.15380694040698,"price_display":"46.15","price_state":"stated","total_value":254030.5534,"total_display":"254,030.55","total_whole":"254,031","shares_owned_after":24600.0,"shares_owned_after_display":"24,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-06-17","scope":"insider","n_lines":2},{"id":2285496,"accession":"0001209191-20-020043","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-020043","line_url":"/filing/0001209191-20-020043","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5504.0,"shares_display":"5,504","price_per_share":46.15380694040698,"price_display":"46.15","price_state":"stated","total_value":254030.5534,"total_display":"254,030.55","total_whole":"254,031","shares_owned_after":35609.0,"shares_owned_after_display":"35,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider","n_lines":2},{"id":9271199,"accession":"0001209191-20-037483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037483","line_url":"/filing/0001209191-20-037483","is_derivative":false,"issuer_cik":"0001751790","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001751790","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5505.0,"shares_display":"5,505","price_per_share":49.426109264305175,"price_display":"49.43","price_state":"stated","total_value":272090.7315,"total_display":"272,090.73","total_whole":"272,091","shares_owned_after":30104.0,"shares_owned_after_display":"30,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2020-06-17","scope":"insider","n_lines":2},{"id":8011522,"accession":"0001209191-19-061189","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-061189","line_url":"/filing/0001209191-19-061189","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001751790","owner_name":"Wolff Stefani","owner_display_name":"Wolff Stefani","owner_url":"/insider/0001751790","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5505.0,"shares_display":"5,505","price_per_share":49.426109264305175,"price_display":"49.43","price_state":"stated","total_value":272090.7315,"total_display":"272,090.73","total_whole":"272,091","shares_owned_after":36909.0,"shares_owned_after_display":"36,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001549595","name":"Nurix Therapeutics, Inc.","url":"/issuer/0001549595","role":"Officer (EVP and COO)","n_filings":5,"first_seen":"2022-05-03","last_seen":"2023-05-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Officer (Chief Development Officer)","n_filings":5,"first_seen":"2019-12-18","last_seen":"2020-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001751790","retrieved_at":"2026-08-24T00:11:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}